Glutamate carboxypeptidase 2
Glutamate carboxypeptidase 2 (178-186) is a synthetic peptide fragment corresponding to amino acid residues 178 through 186 of the human glutamate carboxypeptidase 2 (GCPII) protein, also known as prostate-specific membrane antigen (PSMA). As a defined segment of a well-characterized peptidase, it serves as a valuable molecular tool in the study of enzyme structure, substrate recognition, and the biological functions of GCPII. The sequence is often utilized in biochemical research to dissect protein-protein interactions, investigate binding motifs, and explore the functional domains of PSMA, which is implicated in neurobiology and cancer biology. Its defined structure and relevance to both enzymatic activity and molecular recognition make it a versatile asset for peptide-based research applications.
Enzyme mapping: Researchers employ the 178-186 peptide fragment to probe the structural and functional organization of glutamate carboxypeptidase 2. By using this peptide in binding assays or as a competitive inhibitor, it is possible to map substrate recognition sites and delineate the active region of the enzyme. Such studies are integral for elucidating how GCPII interacts with endogenous substrates, small-molecule inhibitors, or other regulatory proteins, thereby enhancing the understanding of its enzymatic mechanism at a molecular level.
Antibody epitope identification: The defined sequence of this peptide makes it an ideal candidate for generating and characterizing antibodies specific to the 178-186 region of GCPII. It is commonly used as an immunogen or as a standard in immunoassays to determine antibody specificity, map linear epitopes, or validate antibody reactivity. These applications are crucial in the development of sensitive and selective immunodetection tools for research on PSMA expression patterns and functional studies in various biological systems.
Protein interaction studies: The 178-186 fragment can serve as a probe for investigating protein-peptide and protein-protein interactions involving the GCPII protein. Incorporating this peptide into pull-down assays, surface plasmon resonance experiments, or other biophysical techniques enables researchers to identify interaction partners, characterize binding affinities, and define the molecular determinants of recognition. Such approaches are essential for mapping signaling pathways and understanding the broader interactome of PSMA in cellular contexts.
Peptide-based assay development: The synthetic 178-186 peptide provides a well-defined standard for developing and optimizing biochemical assays that monitor GCPII activity, substrate cleavage, or inhibitor screening. By incorporating this fragment into fluorometric, colorimetric, or mass spectrometry-based workflows, laboratories can establish robust and reproducible platforms for quantitative analysis. These assays facilitate high-throughput screening and mechanistic studies, supporting drug discovery and fundamental research on peptidase function.
Structural biology research: The 178-186 segment is frequently utilized in structural studies, such as NMR spectroscopy or crystallography, to resolve the conformational features of GCPII-derived peptides and their complexes with binding partners. Its use allows for detailed analysis of secondary structure, backbone dynamics, and interaction interfaces. These insights contribute to a deeper understanding of the structure-function relationship within the GCPII enzyme and inform rational design of modulators or diagnostic probes targeting this biologically significant protein.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More